Human Gene MIR744 (ENST00000578242.1) from GENCODE V44
  Description: Homo sapiens microRNA 744 (MIR744), microRNA. (from RefSeq NR_030613)
RefSeq Summary (NR_030613): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Gencode Transcript: ENST00000578242.1
Gencode Gene: ENSG00000266297.1
Transcript (Including UTRs)
   Position: hg38 chr17:12,081,899-12,081,996 Size: 98 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksPrimersCTDRNA-Seq ExpressionMicroarray Expression
Other SpeciesmRNA DescriptionsOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr17:12,081,899-12,081,996)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaBioGPS
EnsemblEntrez GeneExonPrimerGencodeHGNCLynx
MalacardsPubMedBioGrid CRISPR DB

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  DL492534 - Novel nucleic acids.
HZ408756 - JP 2015528002-A/1353: CHIRAL CONTROL.
HZ460733 - WO 2015190584-A/230: Kit or device and method for detecting prostate cancer.
HZ461401 - WO 2015190586-A/214: Kit and method for detecting colon cancer.
HZ462243 - WO 2015190591-A/398: Kit and method for detecting breast cancer.
HZ463162 - WO 2015194535-A/256: Kit and method for detecting stomach cancer.
HZ464541 - WO 2015194615-A/359: Kit or device and method for detecting hepatic cancer.
HZ465289 - WO 2015194627-A/342: Kit and method for detecting esophageal cancer.
LG052090 - KR 1020150036642-A/1356: CHIRAL CONTROL.
LY496472 - KR 1020170018406-A/342: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY497044 - KR 1020170016485-A/214: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498442 - KR 1020170018411-A/359: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499246 - KR 1020170018412-A/398: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY499975 - KR 1020170019425-A/256: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY500606 - KR 1020170016490-A/230: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ238824 - WO 2017171048-A/485: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS869525 - Sequence 230 from Patent EP3156483.
MS880561 - Sequence 398 from Patent EP3156498.
MS884231 - Sequence 214 from Patent EP3156499.
MS885094 - Sequence 256 from Patent EP3156503.
MS994480 - Sequence 342 from Patent EP3159406.
FW364589 - Oligonucleotides for modulating target RNA activity.
HI964785 - Sequence 70 from Patent WO2010139812.
HI966378 - Sequence 698 from Patent WO2010139811.
HI967244 - Sequence 698 from Patent WO2010139810.
HV595504 - JP 2010539959-A/885: Micromirs.
HV953993 - JP 2012518421-A/905: METHODS OF DETECTING LUNG CANCER.
HW122348 - JP 2013504331-A/7: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
HW523246 - JP 2014507123-A/31: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS.
HW798901 - WO 2014192907-A/7: Method for detecting miRNA used for differentiating disorders causing motor neuropathy.
HZ074605 - JP 2013535982-A/696: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082742 - JP 2015513906-A/99: Stem Cell Microparticles.
HZ158061 - JP 2015130862-A/885: Micromirs.
HZ186902 - JP 2015146814-A/651: Oligonucleotides for modulating target RNA activity.
HZ436523 - JP 2015529450-A/99: Stem Cell Microparticles.
HZ460547 - WO 2015190584-A/44: Kit or device and method for detecting prostate cancer.
HZ461206 - WO 2015190586-A/19: Kit and method for detecting colon cancer.
HZ461965 - WO 2015190591-A/120: Kit and method for detecting breast cancer.
HZ462963 - WO 2015194535-A/57: Kit and method for detecting stomach cancer.
HZ464323 - WO 2015194615-A/141: Kit or device and method for detecting hepatic cancer.
HZ465075 - WO 2015194627-A/128: Kit and method for detecting esophageal cancer.
HZ482579 - JP 2015535430-A/3085: TERMINALLY MODIFIED RNA.
HZ792510 - JP 2016504050-A/4255: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA400823 - Sequence 70 from Patent WO2011080318.
JA401801 - Sequence 70 from Patent WO2011080315.
JA402808 - Sequence 70 from Patent WO2011080316.
JA405439 - Sequence 70 from Patent EP2336353.
JA427312 - Sequence 645 from Patent WO2011072177.
JA428965 - Sequence 70 from Patent WO2011095623.
JA660686 - Sequence 140 from Patent WO2011131354.
JA682680 - Sequence 148 from Patent WO2011149354.
JA715123 - Sequence 905 from Patent EP2401406.
JA791797 - Sequence 199 from Patent WO2012089772.
JA885401 - Sequence 31 from Patent WO2012083004.
JB022643 - Sequence 485 from Patent WO2013026685.
JB023104 - Sequence 358 from Patent WO2013026684.
JB074943 - Sequence 203 from Patent WO2012168448.
JB174990 - Sequence 22 from Patent WO2012101219.
JB249283 - Sequence 51 from Patent EP2478360.
JB620790 - Sequence 770 from Patent WO2013063544.
JC171727 - Sequence 99 from Patent WO2013150303.
JC244920 - Sequence 548 from Patent WO2012020308.
JC244981 - Sequence 609 from Patent WO2012020308.
JC249568 - Sequence 29 from Patent WO2011138457.
JC515242 - Sequence 5495 from Patent WO2014113089.
JC572538 - Sequence 99 from Patent WO2014125276.
JC582226 - Sequence 99 from Patent WO2014125277.
JE953922 - Sequence 99 from Patent WO2015052526.
JE955675 - Sequence 99 from Patent WO2015052527.
JE978695 - Sequence 140 from Patent EP2865765.
LF137427 - JP 2016507550-A/99: Method of Producing Microparticles.
LF160047 - JP 2016513950-A/113: Oligomers with improved off-target profile.
LF162392 - JP 2016513095-A/99: Stem Cell Microparticles and miRNA.
LF632757 - WO 2016117582-A/186: miRNA biomarkers for mental disorders.
LF953144 - JP 2016534103-A/99: Stem Cell Microparticles and miRNA.
LG005489 - KR 1020150004822-A/99: STEM CELL MICROPARTICLES.
LG053185 - KR 1020150059168-A/99: STEM CELL MICROPARTICLES.
LG240424 - KR 1020160035087-A/99: STEM CELL MICROPARTICLES AND MIRNA.
LP727004 - Sequence 698 from Patent EP2883966.
LP819274 - Sequence 698 from Patent EP3296406.
LP928788 - Sequence 29 from Patent EP3181692.
LP939216 - Sequence 698 from Patent EP3184651.
LP951699 - Sequence 205 from Patent WO2017157650.
LQ072830 - Sequence 3154 from Patent EP2964234.
LQ278597 - Sequence 136 from Patent WO2016066288.
LQ441196 - Sequence 203 from Patent EP3029157.
LV470509 - JP 2016534036-A/99: Stem Cell Microparticles and miRNA.
LX280720 - JP 2016105097-A/7: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
LY405569 - KR 1020160117535-A/874: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY496258 - KR 1020170018406-A/128: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY496849 - KR 1020170016485-A/19: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498224 - KR 1020170018411-A/141: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498968 - KR 1020170018412-A/120: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY499776 - KR 1020170019425-A/57: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY500420 - KR 1020170016490-A/44: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ234259 - JP 2017184756-A/651: Oligonucleotides for modulating target RNA activity.
LZ234338 - JP 2017181518-A/7: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
LZ238563 - WO 2017171048-A/224: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MA260808 - JP 2017505623-A/874: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA406057 - WO 2018155427-A/831: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA420071 - JP 2018518169-A/122: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA646331 - JP 2017113010-A/4255: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA734215 - JP 2017140048-A/3085: TERMINALLY MODIFIED RNA.
MP015347 - Sequence 550 from Patent WO2019016252.
MS637911 - Sequence 28 from Patent WO2017037190.
MS673555 - Sequence 358 from Patent EP3135774.
MS833924 - Sequence 70 from Patent EP3112479.
MS869339 - Sequence 44 from Patent EP3156483.
MS880283 - Sequence 120 from Patent EP3156498.
MS884036 - Sequence 19 from Patent EP3156499.
MS884895 - Sequence 57 from Patent EP3156503.
MS902012 - Sequence 485 from Patent EP3156505.
MS994266 - Sequence 128 from Patent EP3159406.
HZ460927 - WO 2015190584-A/424: Kit or device and method for detecting prostate cancer.
HZ461587 - WO 2015190586-A/400: Kit and method for detecting colon cancer.
HZ462530 - WO 2015190591-A/685: Kit and method for detecting breast cancer.
HZ463355 - WO 2015194535-A/449: Kit and method for detecting stomach cancer.
HZ464774 - WO 2015194615-A/592: Kit or device and method for detecting hepatic cancer.
HZ465507 - WO 2015194627-A/560: Kit and method for detecting esophageal cancer.
LY496690 - KR 1020170018406-A/560: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY497230 - KR 1020170016485-A/400: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498675 - KR 1020170018411-A/592: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499533 - KR 1020170018412-A/685: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY500168 - KR 1020170019425-A/449: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY500800 - KR 1020170016490-A/424: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ239122 - WO 2017171048-A/783: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS869719 - Sequence 424 from Patent EP3156483.
MS880848 - Sequence 685 from Patent EP3156498.
MS884417 - Sequence 400 from Patent EP3156499.
MS885287 - Sequence 449 from Patent EP3156503.
MS994698 - Sequence 560 from Patent EP3159406.
DL491003 - Novel nucleic acids.
FW364590 - Oligonucleotides for modulating target RNA activity.
FW371773 - Human-derived nuclear acids for inhibiting HIV protein expression.
HI964784 - Sequence 69 from Patent WO2010139812.
HI966279 - Sequence 599 from Patent WO2010139811.
HI967145 - Sequence 599 from Patent WO2010139810.
HV595505 - JP 2010539959-A/886: Micromirs.
HW913485 - JP 2015504307-A/245: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ074606 - JP 2013535982-A/697: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083129 - JP 2015513906-A/486: Stem Cell Microparticles.
HZ158062 - JP 2015130862-A/886: Micromirs.
HZ186903 - JP 2015146814-A/652: Oligonucleotides for modulating target RNA activity.
HZ436910 - JP 2015529450-A/486: Stem Cell Microparticles.
HZ482578 - JP 2015535430-A/3084: TERMINALLY MODIFIED RNA.
HZ792509 - JP 2016504050-A/4254: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA400822 - Sequence 69 from Patent WO2011080318.
JA401800 - Sequence 69 from Patent WO2011080315.
JA402807 - Sequence 69 from Patent WO2011080316.
JA405438 - Sequence 69 from Patent EP2336353.
JA427181 - Sequence 514 from Patent WO2011072177.
JA428964 - Sequence 69 from Patent WO2011095623.
JA660698 - Sequence 152 from Patent WO2011131354.
JA791618 - Sequence 20 from Patent WO2012089772.
JA791980 - Sequence 29 from Patent WO2012089753.
JB074894 - Sequence 154 from Patent WO2012168448.
JB620791 - Sequence 771 from Patent WO2013063544.
JB778866 - Sequence 245 from Patent WO2013078283.
JC172114 - Sequence 486 from Patent WO2013150303.
JC244982 - Sequence 610 from Patent WO2012020308.
JC515241 - Sequence 5494 from Patent WO2014113089.
JC572925 - Sequence 486 from Patent WO2014125276.
JC582613 - Sequence 486 from Patent WO2014125277.
JE954309 - Sequence 486 from Patent WO2015052526.
JE956062 - Sequence 486 from Patent WO2015052527.
JE978707 - Sequence 152 from Patent EP2865765.
LF137814 - JP 2016507550-A/486: Method of Producing Microparticles.
LF160988 - JP 2016513950-A/1054: Oligomers with improved off-target profile.
LF162779 - JP 2016513095-A/486: Stem Cell Microparticles and miRNA.
LF953531 - JP 2016534103-A/486: Stem Cell Microparticles and miRNA.
LG005876 - KR 1020150004822-A/486: STEM CELL MICROPARTICLES.
LG053572 - KR 1020150059168-A/486: STEM CELL MICROPARTICLES.
LG240811 - KR 1020160035087-A/486: STEM CELL MICROPARTICLES AND MIRNA.
LP726905 - Sequence 599 from Patent EP2883966.
LP819175 - Sequence 599 from Patent EP3296406.
LP939117 - Sequence 599 from Patent EP3184651.
LQ072829 - Sequence 3153 from Patent EP2964234.
LQ441147 - Sequence 154 from Patent EP3029157.
LQ724406 - Sequence 39 from Patent WO2018096084.
LV470896 - JP 2016534036-A/486: Stem Cell Microparticles and miRNA.
LY405570 - KR 1020160117535-A/875: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ234260 - JP 2017184756-A/652: Oligonucleotides for modulating target RNA activity.
MA260809 - JP 2017505623-A/875: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA646330 - JP 2017113010-A/4254: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA734214 - JP 2017140048-A/3084: TERMINALLY MODIFIED RNA.
MS833923 - Sequence 69 from Patent EP3112479.
MA806273 - WO 2018199275-A/533: Kit, device and method for detection of ovary tumor.
MA803384 - JP 2018183181-A/4255: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA806002 - WO 2018199275-A/262: Kit, device and method for detection of ovary tumor.
MA806559 - WO 2018199275-A/819: Kit, device and method for detection of ovary tumor.
MA803383 - JP 2018183181-A/4254: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA822817 - WO 2019004436-A/630: Kit, device, and method for detection of lung cancer.
MA822482 - WO 2019004436-A/295: Kit, device, and method for detection of lung cancer.
MP129199 - Sequence 99 from Patent EP3470073.
MP162122 - Sequence 99 from Patent WO2019069093.
MA823147 - WO 2019004436-A/960: Kit, device, and method for detection of lung cancer.
MP129586 - Sequence 486 from Patent EP3470073.
MP162509 - Sequence 486 from Patent WO2019069093.
MP280656 - Sequence 76 from Patent WO2019111197.
MP283569 - Sequence 76 from Patent WO2019111198.
LY616588 - KR 1020180129785-A/485: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616327 - KR 1020180129785-A/224: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616886 - KR 1020180129785-A/783: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
MB119869 - WO 2019117270-A/71: Method of aiding detection of head and neck cancer.
MB407124 - WO 2019159884-A/614: Kit, device, and method for detection of dementia.
MB406728 - WO 2019159884-A/218: Kit, device, and method for detection of dementia.
MB407552 - WO 2019159884-A/1042: Kit, device, and method for detection of dementia.
MB473053 - WO 2019208671-A/452: Kit or device and method for detecting bladder cancer.
MB472822 - WO 2019208671-A/221: Kit or device and method for detecting bladder cancer.
MB473219 - WO 2019208671-A/618: Kit or device and method for detecting bladder cancer.
MC002628 - WO 2020027098-A/25: A method for quality evaluation of body fluid sample.
MC002612 - WO 2020027098-A/9: A method for quality evaluation of body fluid sample.
MP395075 - Sequence 173 from Patent EP3565903.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_030613, uc021tqg.1
UCSC ID: ENST00000578242.1
RefSeq Accession: NR_030613

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.